belly fat

belly fat loss

How to Decrease HIV Related Belly Fat Accumulation

In the mid-90s with the advent of the first antiretroviral (AVR) drug combination therapies, Kaposi‚Äôs sarcoma (KS) lesions and lipodystrophy (wasting away of body fat) rapidly faded from public consciousness as signs of HIV infection. Only to be replaced by another symptom that can powerfully impact the health and appearance and health of the HIV …

How to Decrease HIV Related Belly Fat Accumulation Read More »

Update on Egrifta for the reduction of visceral fat accumulation associated with HIV lpodystrophy

Serono launched Egrifta this month. Doctors are calling in the number included in the link below to get the paper work started for insurance reimbursement. It seems that some insurance companies are  already starting to pay for it, but high copays may be required. Serono has a $200 copay assistance per prescription. The total yearly …

Update on Egrifta for the reduction of visceral fat accumulation associated with HIV lpodystrophy Read More »

AIDS Activists Support the Approval of Egrifta- But With Some Conditions for Theratecnologies and Serono

17 May 2010 Paul Tran, BS Pharrn, RPh Advisors and Consultants Staff Center for Drug Evaluation and Research Food and Drug Administration 5630 Fishers Lane, HFD-21 Rockville, MD 20857 Dear Mr. Tran: On behalf ofthe Drug Development Committee (DDC) ofthe AIDS Treatment Activists Coalition (ATAC), I am writing to urge members ofthe Endocrinologic and Metabolic …

AIDS Activists Support the Approval of Egrifta- But With Some Conditions for Theratecnologies and Serono Read More »

FDA Committee Unanimously Recommends Egrifta for Lipodystrophy

FROM POZ.COM May 27, 2010 FDA Committee Unanimously Recommends Egrifta for Lipodystrophy A U.S. Food and Drug Administration (FDA) advisory committee has unanimously recommended that Egrifta (tesamorelin), Montreal-based Theratechnologies’ experimental product for the treatment of excess abdominal fat in HIV-positive people with lipodystrophy, be approved by the agency.  Though the FDA is not required to …

FDA Committee Unanimously Recommends Egrifta for Lipodystrophy Read More »